Common Stock, par value $0.0001 per share
- Symbol
- AVR
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 1.01, 9.01 · 8-K
Anteris Technologies Global Corp.
AVRNASDAQEQUITYCurrent
Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. On September 22, 2026, Anteris Aus Operations Pty Ltd (“AAOPL”), a wholly owned subsidiary of Anteris Technologies Global Corp., and Harvey Industries Group Pty Ltd (“Harvey”, together with AAOPL, the “Parties”), entered into an Amendment (the “Amendment”) to that certain Supply & Quality Agreement, executed May 24, 2024, by and between AAOPL…
Company context
Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients.
Current securities
Registered securities in this filing
Anteris Technologies Global Corp. · 8-K · Filed 2026-09-23
Disclosure sections
Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01.
Entry into a Material Definitive Agreement.
On September 22, 2026, Anteris Aus Operations Pty Ltd (“AAOPL”), a wholly owned subsidiary of Anteris Technologies Global Corp., and Harvey Industries Group Pty Ltd (“Harvey”, together with AAOPL, the “Parties”), entered into an Amendment (the “Amendment”) to that certain Supply & Quality Agreement, executed May 24, 2024, by and between AAOPL and Harvey (the “Agreement”). The Amendment extends the term of the Agreement for a term expiring on the earlier of (i) December 31, 2026 and (ii) the date of execution of a separate supply and quality agreement between the Parties that is intended to replace the Agreement. All of the other material terms of the Agreement remain unchanged and in full force and effect.
The foregoing description of the Amendment in this Current Report on Form 8-K is only a summary and does not purport to be complete and is qualified in its entirety by reference to the Amendment, a copy of which is filed herewith as Exhibit 10.1.